Improved regenerative myogenesis and muscular dystrophy in mice lacking Mkp5.

Duchenne muscular dystrophy (DMD) is a degenerative skeletal muscle disease caused by mutations in dystrophin. The degree of functional deterioration in muscle stem cells determines the severity of DMD. The mitogen-activated protein kinases (MAPKs), which are inactivated by MAPK phosphatases (MKPs), represent a central signaling node in the regulation of muscle stem cell function. Here we show that the dual-specificity protein phosphatase DUSP10/MKP-5 negatively regulates muscle stem cell function in mice. MKP-5 controlled JNK to coordinate muscle stem cell proliferation and p38 MAPK to control differentiation. Genetic loss of Mkp5 in mice improved regenerative myogenesis and dystrophin-deficient mdx mice lacking Mkp5 exhibited an attenuated dystrophic muscle phenotype. Hence, enhanced promyogenic MAPK activity preserved muscle stem cell function even in the absence of dystrophin and ultimately curtailed the pathogenesis associated with DMD. These results identify MKP-5 as an essential negative regulator of the promyogenic actions of the MAPKs and suggest that MKP-5 may serve as a target to promote muscle stem cell function in the treatment of degenerative skeletal muscle diseases.

[1]  A. Bennett,et al.  Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions , 2012, Cellular and Molecular Life Sciences.

[2]  Eric R. Szelenyi,et al.  Time‐course analysis of injured skeletal muscle suggests a critical involvement of ERK1/2 signaling in the acute inflammatory response , 2012, Muscle & nerve.

[3]  S. Delp,et al.  Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice , 2010, Cell.

[4]  B. Olwin,et al.  MAP kinase phosphatase‐1 deficiency impairs skeletal muscle regeneration and exacerbates muscular dystrophy , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  J. Licht,et al.  Sprouty1 Regulates Reversible Quiescence of a Self-Renewing Adult Muscle Stem Cell Pool during Regeneration , 2010, Cell stem cell.

[6]  G. Cossu,et al.  Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. , 2010, The Journal of clinical investigation.

[7]  S. Bhatnagar,et al.  Therapeutic targeting of signaling pathways in muscular dystrophy , 2010, Journal of Molecular Medicine.

[8]  G. Shulman,et al.  MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice. , 2009, The Journal of clinical investigation.

[9]  R. Flavell,et al.  A non‐redundant role for MKP5 in limiting ROS production and preventing LPS‐induced vascular injury , 2009, The EMBO journal.

[10]  D. Gerrard,et al.  Mitogen-activated protein kinase signaling is necessary for the maintenance of skeletal muscle mass. , 2009, American journal of physiology. Cell physiology.

[11]  Eric Chevet,et al.  Mitogen-Activated Protein (MAP) Kinase/MAP Kinase Phosphatase Regulation: Roles in Cell Growth, Death, and Cancer , 2008, Pharmacological Reviews.

[12]  E. Bengal,et al.  Inhibition of Myoblast Differentiation by Tumor Necrosis Factor α Is Mediated by c-Jun N-terminal Kinase 1 and Leukemia Inhibitory Factor* , 2008, Journal of Biological Chemistry.

[13]  M. Buckingham,et al.  Skeletal muscle stem cells. , 2008, Current opinion in genetics & development.

[14]  D. Gerrard,et al.  Modulation of skeletal muscle fiber type by mitogen‐activated protein kinase signaling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Qing Xu,et al.  Involvement of the p38 mitogen-activated protein kinase alpha, beta, and gamma isoforms in myogenic differentiation. , 2008, Molecular biology of the cell.

[16]  M. Rudnicki,et al.  The molecular regulation of muscle stem cell function. , 2008, Cold Spring Harbor symposia on quantitative biology.

[17]  A. Luttun,et al.  uPA deficiency exacerbates muscular dystrophy in MDX mice , 2007, The Journal of Cell Biology.

[18]  M. Caruso,et al.  pRb-Dependent Cyclin D3 Protein Stabilization Is Required for Myogenic Differentiation , 2007, Molecular and Cellular Biology.

[19]  M. Rudnicki,et al.  Asymmetric Self-Renewal and Commitment of Satellite Stem Cells in Muscle , 2007, Cell.

[20]  S. Keyse,et al.  Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases , 2007, Oncogene.

[21]  D. Gerrard,et al.  Extracellular signal-regulated kinase pathway is differentially involved in beta-agonist-induced hypertrophy in slow and fast muscles. , 2007, American journal of physiology. Cell physiology.

[22]  E. Wagner,et al.  Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation , 2007, The EMBO journal.

[23]  E. Nishida,et al.  Notch Signaling Suppresses p38 MAPK Activity via Induction of MKP-1 in Myogenesis* , 2007, Journal of Biological Chemistry.

[24]  R. Dickinson,et al.  Diverse physiological functions for dual-specificity MAP kinase phosphatases , 2006, Journal of Cell Science.

[25]  P. Neufer,et al.  Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity. , 2006, Cell metabolism.

[26]  Daniel J Garry,et al.  Muscle stem cells in development, regeneration, and disease. , 2006, Genes & development.

[27]  A. Keren,et al.  The p38 MAPK signaling pathway: A major regulator of skeletal muscle development , 2006, Molecular and Cellular Endocrinology.

[28]  P. Muñoz-Cánoves,et al.  Regulation of skeletal muscle gene expression by p38 MAP kinases. , 2006, Trends in cell biology.

[29]  Charlotte Collins,et al.  Direct Isolation of Satellite Cells for Skeletal Muscle Regeneration , 2005, Science.

[30]  A. Wagers,et al.  Cellular and Molecular Signatures of Muscle Regeneration: Current Concepts and Controversies in Adult Myogenesis , 2005, Cell.

[31]  A. Bennett,et al.  The Noncatalytic Amino Terminus of Mitogen-Activated Protein Kinase Phosphatase 1 Directs Nuclear Targeting and Serum Response Element Transcriptional Regulation , 2005, Molecular and Cellular Biology.

[32]  N. Jones,et al.  The p38α/β MAPK functions as a molecular switch to activate the quiescent satellite cell , 2005, The Journal of cell biology.

[33]  A. Khurana,et al.  Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation , 2004, Journal of Muscle Research & Cell Motility.

[34]  R. Flavell,et al.  Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5 , 2004, Nature.

[35]  T. Underhill,et al.  Inhibition of p38 MAPK signaling promotes late stages of myogenesis , 2003, Journal of Cell Science.

[36]  C. Gauthier-Rouvière,et al.  Transforming growth factor β activates Rac1 and Cdc42Hs GTPases and the JNK pathway in skeletal muscle cells , 2002 .

[37]  Ichizo Nishino,et al.  Muscular dystrophies , 2002, Current opinion in neurology.

[38]  C. Gauthier-Rouvière,et al.  Transforming growth factor beta activates Rac1 and Cdc42Hs GTPases and the JNK pathway in skeletal muscle cells. , 2002, Biology of the cell.

[39]  T. Hawke,et al.  Myogenic satellite cells: physiology to molecular biology. , 2001, Journal of applied physiology.

[40]  N. Jones,et al.  ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion , 2001, Journal of cellular physiology.

[41]  Y. Matsuda,et al.  Expression and comparative chromosomal mapping of MKP-5 genes DUSP10/Dusp10 , 2000, Cytogenetic and Genome Research.

[42]  M. Rudnicki,et al.  A new look at the origin, function, and "stem-cell" status of muscle satellite cells. , 2000, Developmental biology.

[43]  J. D. Porter.  Introduction to muscular dystrophy , 2000, Microscopy research and technique.

[44]  A. Ashworth,et al.  MKP5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases , 1999, Oncogene.

[45]  G. Falcone,et al.  Distinct effects of Rac1 on differentiation of primary avian myoblasts. , 1999, Molecular biology of the cell.

[46]  E. Nishida,et al.  Molecular Cloning and Characterization of a Novel Dual Specificity Phosphatase, MKP-5* , 1999, The Journal of Biological Chemistry.

[47]  M. Caruso,et al.  Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation , 1999, Molecular and Cellular Biology.

[48]  P. Cohen,et al.  Stress-activated Protein Kinase-2/p38 and a Rapamycin-sensitive Pathway Are Required for C2C12 Myogenesis* , 1999, The Journal of Biological Chemistry.

[49]  S. Tapscott,et al.  Mitogen-activated Protein Kinase Pathway Is Involved in the Differentiation of Muscle Cells* , 1998, The Journal of Biological Chemistry.

[50]  N. Tonks,et al.  Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. , 1997, Science.

[51]  R. Bischoff.  Chemotaxis of skeletal muscle satellite cells , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[52]  J. Florini,et al.  The Mitogenic and Myogenic Actions of Insulin-like Growth Factors Utilize Distinct Signaling Pathways* , 1997, The Journal of Biological Chemistry.

[53]  A. Wolfman,et al.  Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras , 1997, Oncogene.

[54]  M. R. Calera,et al.  Stimulation of C2C12 myoblast growth by basic fibroblast growth factor and insulin-like growth factor 1 can occur via mitogen-activated protein kinase-dependent and -independent pathways , 1996, Molecular and cellular biology.

[55]  S. S. Rao,et al.  Positive and Negative Regulation of D-type Cyclin Expression in Skeletal Myoblasts by Basic Fibroblast Growth Factor and Transforming Growth Factor β , 1995, The Journal of Biological Chemistry.

[56]  R. Gill,et al.  Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. , 1995, Oncogene.

[57]  H. Sweeney,et al.  Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Shrager,et al.  The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy , 1991, Nature.

[59]  Eric P. Hoffman,et al.  Dystrophin: The protein product of the duchenne muscular dystrophy locus , 1987, Cell.

[60]  H. Blau,et al.  Defective myoblasts identified in Duchenne muscular dystrophy. , 1983, Proceedings of the National Academy of Sciences of the United States of America.